Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03506997
Title Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (PERSEUS1)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors Institute of Cancer Research, United Kingdom
Indications

prostate adenocarcinoma

Therapies

Pembrolizumab

Age Groups: senior | adult
Covered Countries

Additional content available in CKB BOOST